Results 221 to 230 of about 29,090 (255)
Some of the next articles are maybe not open access.
Mycoses, 2007
SummaryThe guideline on onychomycosis, as passed by the responsible German medical societies, is presented in the present study.
Seebacher, Claus +14 more
openaire +4 more sources
SummaryThe guideline on onychomycosis, as passed by the responsible German medical societies, is presented in the present study.
Seebacher, Claus +14 more
openaire +4 more sources
International Journal of Dermatology, 1987
Quaderni di Cooperazione Sanitaria ; info:eu-repo/semantics ...
André, Josette, Achten, Georges
openaire +2 more sources
Quaderni di Cooperazione Sanitaria ; info:eu-repo/semantics ...
André, Josette, Achten, Georges
openaire +2 more sources
Clinics in Dermatology, 2010
Onychomycosis is a frequent nail disease caused by dermatophytes, yeasts, and nondermatophyte molds. Trichophyton rubrum, T mentagrophytes, and Epidermophyton floccosum are the most common etiologic agents worldwide. Candida spp are the most frequent among the yeasts.
Oliverio, Welsh +2 more
openaire +2 more sources
Onychomycosis is a frequent nail disease caused by dermatophytes, yeasts, and nondermatophyte molds. Trichophyton rubrum, T mentagrophytes, and Epidermophyton floccosum are the most common etiologic agents worldwide. Candida spp are the most frequent among the yeasts.
Oliverio, Welsh +2 more
openaire +2 more sources
JAMA Dermatology
This Patient Page describes the risk factors, clinical features, diagnosis, and treatment of onychomycosis.
Inès Zaraa +2 more
openaire +4 more sources
This Patient Page describes the risk factors, clinical features, diagnosis, and treatment of onychomycosis.
Inès Zaraa +2 more
openaire +4 more sources
Clinics in Podiatric Medicine and Surgery, 1996
The prevalence and clinical types of onychomycosis and diagnostic methods are reviewed in this article. The need for correct identification of the causative organism is emphasized. The use of oral and topical therapeutic agents is outlined, with specific emphasis on relevant research data and potential side effects of these agents.
A F, Hoffman, V R, Driver
openaire +2 more sources
The prevalence and clinical types of onychomycosis and diagnostic methods are reviewed in this article. The need for correct identification of the causative organism is emphasized. The use of oral and topical therapeutic agents is outlined, with specific emphasis on relevant research data and potential side effects of these agents.
A F, Hoffman, V R, Driver
openaire +2 more sources
Journal of the European Academy of Dermatology and Venereology, 2020
AbstractOnychomycosis is a fungal infection of the nail, causing discoloration and thickening of the affected nail plate, and is the most common nail infection worldwide. Onychomycosis was initially thought to be predominantly caused by dermatophytes; however, new research has revealed that mixed infections and those caused by non‐dermatophyte moulds ...
Nadia Stec +8 more
openaire +3 more sources
AbstractOnychomycosis is a fungal infection of the nail, causing discoloration and thickening of the affected nail plate, and is the most common nail infection worldwide. Onychomycosis was initially thought to be predominantly caused by dermatophytes; however, new research has revealed that mixed infections and those caused by non‐dermatophyte moulds ...
Nadia Stec +8 more
openaire +3 more sources
Origins of onychomycosis [PDF]
Clinics in Podiatric Medicine and Surgery, 2004 The invasion of human toenails by microorganisms is not always understood. Efficacious treatment, however, depends on establishing proper identification and understanding the improper diagnosis results in failed treatment. Most medical treatment presently is directed toward several fungal species.
openaire +3 more sources
The diagnosis of onychomycosis
Dermatologic Clinics, 2003The prevalence of onychomycosis is increasing and the primary pathogens may be dermatophytes, nondermatophyte molds, or Candida spp. It may not be satisfactory to treat onychomycosis on the basis of clinical diagnosis alone. Laboratory diagnosis is an important component of the proper management of this fungal infection.
James M. Mahoney +2 more
openaire +3 more sources
Efinaconazole in Onychomycosis
American Journal of Clinical Dermatology, 2021Onychomycosis is a fungal nail infection that causes nail discoloration, nail plate thickening, and onycholysis. Efinaconazole 10% topical solution is an FDA-approved treatment for onychomycosis patients aged 6 years and above. The drug functions as an antifungal by disrupting ergosterol synthesis in the fungal cell membrane.
Aditya K. Gupta, Mesbah Talukder
openaire +2 more sources